# Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

> **NCT05473325** · — · UNKNOWN · sponsor: **Willows Health** · enrollment: 2000 (estimated)

## Conditions studied

- Diabetes
- Chronic Kidney Diseases
- Cancer
- Bowel Disease
- Cardiovascular Diseases
- Mononucleosis
- Flu
- Heart Diseases
- HIV Infections
- AIDS and Infections
- Bulimia
- Chest Infections
- Arthritis
- Leukaemia
- Alcoholic Liver Disease
- Allergies
- Alzheimer Disease
- Appendicitis
- Eczema
- Bronchitis
- Cellulitis
- Cirrhosis
- Depression
- Gout
- High Cholesterol
- Indigestion
- Obesity
- Osteoporosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05473325
- **Lead sponsor:** Willows Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2025-06-22
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2022-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05473325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05473325, "Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05473325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*